group, while APO-negative group exhibited moderate ED. We analyzed global gene expression in APO-positive group and APOnegative group, and focused on same changing trend within groups. In microarray analysis, 16 candidate genes were noted to be altered based on magnitude of expression changes, which includes 1 step up-regulated and 15 step down-regulated genes compared with the age matched normal controls. In vivo experiment exhibited erectile function in AAV-S100A1 group was markedly increased in the diabetic rats compared with the AAV-GFP groups. Mechanistically, S100A1 supplementation enhanced NO-cGMP and upstream VEGFR2/Akt signaling pathway. Consistented with in vivo experiments, in vitro study confirmed S100A1 compromised endothelial nitric oxide synthase (eNOS) activity in ECs by triggered the rapid cellular internalization of VEGFR2 and activated protein kinase C (PKC) hyperactivation which was blocked in the peresence of Calphostin-C. Moreover, transfection of AECs with small interfering RNA (siRNA) targeting either PKCa, d, or ε confirmed that by regulating VEGFR2 expression and activation, PKC ε expression is critical for activation of Akt and eNOS by S100A1.
group, while APO-negative group exhibited moderate ED. We analyzed global gene expression in APO-positive group and APOnegative group, and focused on same changing trend within groups. In microarray analysis, 16 candidate genes were noted to be altered based on magnitude of expression changes, which includes 1 step up-regulated and 15 step down-regulated genes compared with the age matched normal controls. In vivo experiment exhibited erectile function in AAV-S100A1 group was markedly increased in the diabetic rats compared with the AAV-GFP groups. Mechanistically, S100A1 supplementation enhanced NO-cGMP and upstream VEGFR2/Akt signaling pathway. Consistented with in vivo experiments, in vitro study confirmed S100A1 compromised endothelial nitric oxide synthase (eNOS) activity in ECs by triggered the rapid cellular internalization of VEGFR2 and activated protein kinase C (PKC) hyperactivation which was blocked in the peresence of Calphostin-C. Moreover, transfection of AECs with small interfering RNA (siRNA) targeting either PKCa, d, or ε confirmed that by regulating VEGFR2 expression and activation, PKC ε expression is critical for activation of Akt and eNOS by S100A1.
CONCLUSIONS: Microarray analysis identified 82 diabeticrelated molecular alterations. Among them, S100A1 was significantly step-down regulated. S100A1 supplementation improves erectile function in rats with DED probably by its pro-angiogenic effects that associated with the increased expression, internalization of VEGFR2 and PKC ε hyperactivation. These finding provides evidence for a potential new target for DED management.
Source of Funding: This work was supported by grants from the National Natural Science Foundation of China (NSFC #81501246)
MP43-08
INTRODUCTION AND OBJECTIVES: Intracellular calcium concentration regulates multiple cellular functions including smooth muscle contraction. The key players of store operated calcium entry (SOCE), stromal interaction molecule (STIM) and Orai calcium channels have been proposed as emergent therapeutic targets in cardiovascular pathophysiology. The aim of this work was to evaluate the contribution of STIM/Orai to human penile tissue contraction and to analyze the influence of erectile dysfunction (ED) at functional and expression levels.
METHODS: Human penile resistance arteries (HPRA) and corpus cavernosum (HCC) were dissected from cavernosal specimens from 15 organ donors (OD) without history of ED and from 20 ED patients undergoing penile prosthesis insertion and functionally evaluated in wire myographs and organ chambers, respectively. One or more cardiovascular risk factors were present in all ED patients. Immunofluorescence was used for localization and quantification STIM-1, Orai1 and Orai3 expression in HCC.
RESULTS: Norepinephrine (NE)-induced contractions were significantly reduced by inhibition of Orai channels with YM-58483 (20 mM) in both HCC and HPRA from either OD or ED subjects. However, these the effects were more marked in ED (19.1AE9.1% vs.47.3AE13.1% and 11.5AE2.8% vs.28.7AE2.7% reduction in Emax to NE in HCC and HPRA, respectively). Orai inhibitor also reduced thromboxane-and KCl-induced contractions of penile tissues. In fact, addition of YM-58483 concentration-dependently relaxed precontracted HPRA and HCC. These relaxations were significantly more pronounced in tissues from ED patients (EC50 7.5 vs. 1.3 mM and 10.5 vs. 1.3 mM, for HCC and HPRA, respectively). Expression of STIM-1, Orai1 and Orai3 was detected in HCC from all subjects.
Increased expression of Orai1 (+47.5AE10.1) and Orai3 (+82.2AE14.4%, p<0.05) but not STIM-1 was detected in HCC from ED patients.
CONCLUSIONS: STIM/Orai system plays a relevant role in penile smooth muscle contraction in ED. This fact suggests that STIM/ Orai could be a potential therapeutic strategy to reduce penile contractile tone in ED.
Source of Funding: Instituto de Salud Carlos III (MINECO, Spanish Government, PI15/00674, PI15/01160, PI15/01969) and FEDER funds.
MP43-09 EFFECTS OF PLATELET RICH PLASMA ON IMPROVING ERECTILE DYSFUNCTION IN STREPTOZOTOCIN-INDUCED DIABETIC RATS
ChunHou Liao*, YiNo Wu, HanSun Chiang, New Taipei City, Taiwan INTRODUCTION AND OBJECTIVES: Platelet rich plasma (PRP) has shown to prevent the atrophy of corporal smooth muscle cell and enhance the regeneration of nerve fiber in cavernous nerve injury rat model. In this study, we investigate the effects of PRP on recovery of erectile dysfunction in streptozotocin (STZ) -induced diabetic rats.
METHODS: Six-week-old SD male rats received intraperitoneal (IP) injection of STZ (65mg/kg) or vehicle injection after a 16 hour fast. Twelve weeks later, the erectile function in the entire rat was assessed by measuring intracavernosal pressure (ICP) and other functional parameters of erectile function. Diabetics with erectile dysfunction (ED) rat were divided into two groups: the intracavernosal (IC) injection vehicleonly or PRP treatment. The control without STZ injection and diabetic rat without ED were as a control. Four weeks after treatment, erectile function was assessed by measuring ICP. Penile tissues were collected to undergoing the histomorphometrically analyzed and further perform ultrastructural analysis of the corpus cavernosum.
RESULTS: PRP treated group increased all erectile function parameters at 28 day post-treatment. Ultrastructural analysis revealed PRP improving erectile dysfunction of diabetic rats is through tissueprotective effect to keep integrity the corpus cavernosum.
CONCLUSIONS: PRP treatment improved erectile function in STZ-induced diabetic rats through protection of corpus cavernosum. PRP may have the potential for clinical use of diabetes with ED. It can provide another way for the treatment of ED with diabetic. 
MP43-10 THE ENDOCANNABINOID SYSTEM IN MALE REPRODUCTIVE FUNCTION: EXPRESSION AND LOCALIZATION OF FATTY ACID AMIDE HYDROLASE (FAAH) IN THE SEMINAL VESICLES AND VAS DEFERENS
Stefan Ueckert*, Hannover, Germany; Giorgia Colciago, Fabio Benigni, Milano, Italy; Andreas Bannowsky, Rendsburg, Germany; Markus Kuczyk, Hannover, Germany; Petter Hedlund, Lund, Sweden
INTRODUCTION AND OBJECTIVES:
The endocannabinoid system (ECS), comprising the cannabinoid receptors (CBR), their ligands, and enzymes controlling the turn-over of (endo)cannabinoids (anandamide, tetrahydrocannabinol ¼ THC) , has been suggested to be involved in male reproductive function. As information is scares on the expression of the ECS in human male reproductive tissues, the present study aimed to investigate in the human seminal vesicles (SV) and Vas deferens (VD) by means of molecular biology (RT-PCR) and immunohistochemistry (IHC)/immunofluorescence the expression and distribution of Fatty Acid Amide Hydrolase (FAAH, isoforms 1 and 2, an enzyme known to degrade/hydrolyze cannabinoids, such as anandamide).
METHODS: Macroscopically normal specimens of VS and VD were obtained from 5 male subjects who underwent pelvic surgery for urological malignancies (carcinoma of the prostate/urinary bladder). The tissue was processed for molecular biology analysis (Polymerase Chain Reaction ¼ RT-PCR), Western blotting and immunohistochemistry. Cryostat sections were exposed to specific antibodies directed against FAAH1 and FAAH2, visualization was commenced by means of immunofluorescence.
RESULTS: All specimens expressed PCR products corresponding to FAAH1 (260 bp) and FAAH2 (387 bp). Western blot analysis displayed distinct lanes at positions of the expected molecular weight of the FAAH1 (63 kDa) and FAAH2 protein (68 kDa). IHC revealed cytosolic staining for FAAH1 and FAAH2 in cuboidal cells of the pseudo-stratified epithelial multilayer. No immunoreactivity was detected in the smooth musculature or nerve fibers transversing the tissue.
CONCLUSIONS: Genes encoding for FAAH1 and FAAH2 are highly expressed in the human SV and VD. Considering the localization of the enzymes (as demonstrated by means of IHC), the ECS may be involved in epithelial homeostasis/secretory function rather than autonomic mechano-afferent signaling (control of smooth muscle).
Source of Funding: none

MP43-11 JAK2 KNOCKOUT IMPROVES ERECTILE FUNCTION IN DIABETIC MICE THROUGH ATTENUATION OF FIBROSIS AND APOPTOSIS
Hao Li, Yinwei Chen, Gaurab Pokhrel*, Jun Yang, Tao Wang, Shaogang Wang, Jihong Liu, Wuhan, China, People's Republic of INTRODUCTION AND OBJECTIVES: Janus kinase 2/signal transducer and activator of transcription 3 (JAK2/STAT3) pathway is activated in diabetes condition and may lead to fibrosis and apoptosis in many tissues. We performed this study to investigate the effect of JAK2 knockout on the diabetic erectile dysfunction in mice, both in vivo and in vitro.
METHODS: Cre+/+-JAK2fl/fl mice were used in our study, in which the JAK2 deficiency could be induced by tamoxifen. For the in vivo study, thirty animals were divided into three groups: (1) nondiabetic control group, (2) diabetic group, and (3) diabetic JAK2-/-group. Diabetes was induced by introperitoneal injection of 60mg/kg streptozotocin for 5 consecutive days. 12 weeks later, JAK2 knockout was induced by intraperitoneal injection of 20mg/kg tamoxifen dissolved in corn oil for 4 consecutive days in diabetic JAK2-/-group. After 4 weeks, erectile function was measured by electrical stimulation of the cavernous nerve, and ratio between intracavernosal pressure (ICP) and mean systemic arterial blood pressure (MAP) was calculated. After that penis tissue was harvested. Expression of JAK2/STAT3 pathway, transforming growth factor beta 1 (TGF-b1) , phosphorylated Smad2/3 (P-Smad2/3), Smad2/ 3 and collagen-IV in corpus cavernosum were measured by western blot. The deposition of extracellular collagen was determined by Masson's staining. Apoptosis was detected with TUNEL. For the in vitro study, primary cavernous smooth muscle cells (SMCs) were extracted from Cre+/+-JAK2fl/fl mice. Cells were exposed to high glucose (30mM) to mimic diabetes condition. The effect of JAK2 knockout on the reactive oxygen species (ROS) and Ca2+ level in SMCs was investigated.
RESULTS: The ICP/MAP was reduced in diabetic mice compared with control group, but was improved by JAK2 knockout. The expression of JAK2, phosphorylated STAT3, TGF-b1, P-Smad2/3, and collagen-IV were all decreased by JAK2 knockout in diabetic mice. JAK2 knockout reduced the ratio of collagen to smooth muscle and apoptosis in corpus cavernosum. In cavernous SMCs, JAK2 knockout could attenuate the ROS and Ca2+ levels in high glucose condition.
CONCLUSIONS: JAK2/STAT3 pathway might play a role in the development of diabetic erectile dysfunction. JAK2 knockout could improve the erectile function in diabetic mice by reducing the fibrosis and apoptosis in corpus cavernosum.
